: Halofuginone blocks the TGF-β/Smad3 cascade in U2OS cells. A. U2OS cells were treated for 4 hours with halofuginone as indicated and then for 30 min in the presence or absence of TGF-β (5 ng/ml). Phospho-Smad3 levels were detected by Western Blot analysis of U2OS whole cell lysates (upper panel). Anti-Smad3 antibody was used as internal control (lower panel). B. U2OS cells were transfected with the Smad3/4-specific construct (CAGA) 9 -luc. 24 h after transfection, cells were treated for 4 hours with halofuginone as indicated and then for 6 hours in presence or absence of TGF-β (5 ng/ml). Bars indicate mean ± S.D. of at least two independent experiments carried out in triplicate (*p < 0.05).
